Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.580 | 8.580 | 0.000 |
Stocks | 92.560 | 92.580 | 0.020 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.520 | 19.260 |
Price to Book | 3.229 | 2.993 |
Price to Sales | 4.145 | 2.630 |
Price to Cash Flow | 14.058 | 11.182 |
Dividend Yield | 0.880 | 2.191 |
5 Years Earnings Growth | 12.171 | 12.829 |
Number of long holdings: 219
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Regeneron Pharma | US75886F1075 | 7.57 | 716.68 | +0.31% | |
Gilead | US3755581036 | 7.54 | 94.41 | +0.49% | |
Vertex | US92532F1003 | 7.27 | 410.65 | +0.61% | |
Amgen | US0311621009 | 7.21 | 263.18 | -0.50% | |
Moderna | US60770K1079 | 4.27 | 40.43 | +0.40% | |
AstraZeneca ADR | US0463531089 | 3.53 | 66.52 | +0.33% | |
Biogen | US09062X1037 | 3.21 | 149.90 | +0.59% | |
Alnylam | US02043Q1076 | 2.92 | 242.50 | -0.31% | |
ProShares Ultra Nasdaq Biotechnology | US74347R2141 | 2.14 | 52.77 | +1.11% | |
Illumina | US4523271090 | 1.58 | 134.96 | -0.18% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GF NASDAQ 100 Index Fund QDII USD | 1.78B | 22.51 | 7.25 | - | ||
GF Global Selction Eq QDII USD | 1.19B | 22.86 | -0.04 | - | ||
GF American Estate Index QDII USD | 24.43M | 14.35 | 1.05 | 4.46 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review